When we review insulin intensification studies [26, 27, 42, 51] and real-world basal insulin titration studies [43–45, 51] in T2DM patients, it seems that clinical inertia persists overtime and a growing body of evidence shows that there is often a disconnection between the setting and the achievement of treatment targets. Here, INS is linked to type 2 diabetes mellitus.